$24.95
+0.28 (+1.14%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+2.21%
YTD
-8.07%
Open$24.92
Previous Close$24.67
Day High$25.18
Day Low$24.26
52W High$38.26
52W Low$20.23
Volume—
Avg Volume2.29M
Market Cap2.55B
P/E Ratio—
EPS$-0.81
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$28.48
Below
SMA 200
$22.69
Above
RSI (14)
44
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+148.8% upside
Current
$24.95
$24.95
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 150.07M | 113.79M | 476.44M |
| Net Income | -85,906,990 | -58,626,244 | -46,993,180 |
| Profit Margin | -57.2% | -54.4% | -9.9% |
| EBITDA | -388,110,957 | -279,576,440 | -41,088,618 |
| Free Cash Flow | — | — | -33,034,013 |
| Rev Growth | +31.9% | +31.9% | -6.6% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |